ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,687,000 | +140.8% | 112,500 | +80.0% | 0.60% | +80.7% |
| Q1 2016 | $1,531,000 | -58.8% | 62,500 | -44.4% | 0.33% | -39.0% |
| Q4 2015 | $3,716,000 | -9.3% | 112,500 | -10.0% | 0.54% | +4.2% |
| Q3 2015 | $4,095,000 | -38.2% | 125,000 | 0.0% | 0.52% | -19.6% |
| Q2 2015 | $6,621,000 | +52.9% | 125,000 | -16.7% | 0.65% | +43.9% |
| Q1 2015 | $4,329,000 | – | 150,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |